Increased vascular endothelial growth factor (VEGF) and transforming growth factorβ (TGFβ) in experimental autoimmune uveoretinitis:: upregulation of VEGF without neovascularization

被引:71
|
作者
Vinores, SA
Chan, CC
Vinores, MA
Matteson, DM
Chen, YS
Klein, DA
Shi, A
Ozaki, H
Campochiaro, PA
机构
[1] Johns Hopkins Univ Hosp, Sch Med, Wilmer Ophthalmol Inst, Baltimore, MD 21287 USA
[2] NEI, Immunol Lab, NIH, Bethesda, MD 20892 USA
[3] Cathay Gen Hosp, Taipei, Taiwan
关键词
vascular endothelial growth factor; transforming growth factor beta; experimental autoimmune uveoretinitis; retina; blood-retinal barrier;
D O I
10.1016/S0165-5728(98)00075-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Experimental autoimmune uveoretinitis (EAU) was induced in Lewis rats and B10.A mice by immunization with S-antigen (S-Ag) to study the potential roles of vascular endothelial growth factor (VEGF) and the beta(1) and beta(2) isoforms of transforming growth factor (TGF(beta 1) staining for VEGF, TGF(beta 1) and TGF(beta 2)) during the progression of the disease. VEGF has been implicated as an angiogenic factor in ischemic retinopathies; however, Lewis rats developing EAU have high levels of VEGF in the retina, but no neovascularization. In the present study, immunohistochemical staining for VEGF, TGF(beta 1) and TGF(beta 2) was performed on the retinas of Lewis rats developing EAU or with oxygen-induced ischemic retinopathy. In rats immunized with S-antigen, a marked upregulation of VEGF was immunohistochemically visualized from the inner nuclear layer to the inner limiting membrane prior to blood-retinal barrier (BRB) failure and lymphocytic infiltration. VEGF is normally induced by hypoxia and its induction leads to neovascularization. Coincident with the increase in VEGF, there was increased immunoreactivity for TGF(beta 1) and TGF(beta 2) within the same layers of the retina. In contrast, rats with ischemic retinopathy and retinal neovascularization showed only a modest increase in VEGF immunoreactivity, which is largely confined to retinal ganglion cells and inner retinal vessels, and little or no increase in TGF(beta 1) or TGF(beta 2). In addition, in mice developing EAU, which does not have an abrupt onset as it does in rats and may involve neovascularization, a comparable upregulation of VEGF in the inner retina to that seen in rats developing EAU occurs with no increase in TGF(beta 1) or TGF(beta 2). Since TGF(beta) can inhibit endothelial cell proliferation, it is likely that an increase in TGF(beta) may prevent VEGF from exerting its endothelial growth activity in the rat EAU model, but VEGF may be operative in inducing BRB failure. These data suggest that there is a complex interaction among growth factors in the retina and that retinal neovascularization may require an imbalance between stimulatory and inhibitory factors. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:43 / 50
页数:8
相关论文
共 50 条
  • [1] Vascular Endothelial Growth Factor (VEGF) in Autoimmune Diseases
    JozÉlio Freire Carvalho
    Miri Blank
    Yehuda Shoenfeld
    Journal of Clinical Immunology, 2007, 27 : 246 - 256
  • [2] Vascular endothelial growth factor (VEGF) in autoimmune diseases
    Freire Carvalho, Jozelio
    Blank, Miri
    Shoenfeld, Yehuda
    JOURNAL OF CLINICAL IMMUNOLOGY, 2007, 27 (03) : 246 - 256
  • [3] Vascular endothelial growth factor (VEGF), transforming growth factor beta (TGF), angiostatin, and endostatin are increased in radiotherapy-induced gastrointestinal toxicity
    Stansborough, Romany L.
    Bateman, Emma H.
    Al-Dasooqi, Noor
    Bowen, Joanne M.
    Wignall, Anthony
    Keefe, Dorothy M.
    Yeoh, Ann S.
    Logan, Richard M.
    Yeoh, Eric E. K.
    Stringer, Andrea M.
    Gibson, Rachel J.
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2018, 94 (07) : 645 - 655
  • [4] Increased vascular endothelial growth factor (VEGF) immunostaining in preeclampsia
    Simmons, LA
    Hennessy, A
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 49A - 49A
  • [5] Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor β-1
    Harmey, JH
    Dimitriadis, E
    Kay, E
    Redmond, HP
    Bouchier-Hayes, D
    ANNALS OF SURGICAL ONCOLOGY, 1998, 5 (03) : 271 - 278
  • [6] Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor β-1
    Judith H. Harmey
    Evdokia Dimitriadis
    Elaine Kay
    H. Paul Redmond
    David Bouchier-Hayes
    Annals of Surgical Oncology, 1998, 5 : 271 - 278
  • [7] VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) ANTAGONISTS INHIBIT RETINAL NEOVASCULARIZATION
    AIELLO, LP
    PIERCE, EA
    ROBINSON, GS
    FERRARA, N
    SMITH, LE
    DIABETES, 1995, 44 : A53 - A53
  • [8] Vascular endothelial growth factor (VEGF) in endometriosis
    Donnez, J
    Smoes, P
    Gillerot, S
    Casanas-Roux, F
    Nisolle, M
    HUMAN REPRODUCTION, 1998, 13 (06) : 1686 - 1690
  • [9] Vascular endothelial growth factor (VEGF) pathway
    Nilsson, Monique
    Heymach, John V.
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (08) : 768 - 770
  • [10] Macrophage expression of tissue factor (TF) and vascular endothelial growth factor (VEGF) in choroidal neovascularization
    Grossniklaus, HE
    Dithmar, S
    Wallace, TM
    Ketkar, NN
    Lawson, DH
    Cohen, C
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S231 - S231